The score is not available for this stock. This could be because (a) the market cap of the... Read More
Value score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
Price Momentum score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
QVM score
The score is not available for this stock. This could be because (a) the market cap of the... Read More
BIOGEN Key Metrics
BIOGEN Share Price
Stock Analysis
Snapshot
Shareholding Pattern
Bulk, Block & Insider Trades
Corporate Actions
Company Profile
BIOGEN Share Price
BIOGEN
1 Week returns: -
1 Month returns: -
1 Year returns: -
3 Years CAGR: -
5 Years CAGR: -
Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
BIOGEN Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PB is at a discount to industry median
Low Debt to Equity, not much change from last year
Negative
Low and declining ROE
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0611682.
Snapshot
See detailed analysis
BIOGEN Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
BIOGEN Bulk, Block & Insider Trades
BIOGEN Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Stock split
Stock split(1 : 10)Nominal value change from Rs. 10 to Rs. 1 Ex-date: 29th Jul 2003 Announced on: 8th Jul 2003
Company Profile
Biogen Pharmachem Industries Limited is an India-based company, which is not engaged in any activity. The Company is looking for the right opportunity to make the Company operational.
Key personnel
Mr. Akshay MakadiyaD
Chief Financial Officer, Executive Director
Shri. Girishbhai Gatubhai Doshi
Compliance Officer
Jivan Satish KatheD
Additional Director
Ms. Aishwarya Gopalbhai ModiD
Additional Director
Mr. Rakesh Bhailalbhai PatelD
Additional Director
Mr. Rakesh TewariD
Additional Director
Mr. Udaybhai Arvindbhai PatelD
Non-Executive Director
Ms. Manishaben MuchhalaD
Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Biogen Pharmachem Industries Ltd.?
The current share price of Biogen Pharmachem Industries Ltd. is ₹ 0.73 as of 09 Jan 2026.
What is the PE ratio of Biogen Pharmachem Industries Ltd.?
The Price-to-Earnings (PE) ratio of Biogen Pharmachem Industries Ltd. is 54.44 as of the latest financial data.
What is the ROE and ROCE of Biogen Pharmachem Industries Ltd.?
Biogen Pharmachem Industries Ltd. has a Return on Equity (ROE) of -0.39% and a Return on Capital Employed (ROCE) of -1.52% as per the latest financial reports.
What is the market cap of Biogen Pharmachem Industries Ltd.?
The market capitalization of Biogen Pharmachem Industries Ltd. stands at ₹ 65.89 Cr.
What is the dividend yield of Biogen Pharmachem Industries Ltd.?
The dividend yield of Biogen Pharmachem Industries Ltd. is 0.00% based on the current market price.
What is the RSI of Biogen Pharmachem Industries Ltd.?
The Relative Strength Index (RSI) of Biogen Pharmachem Industries Ltd. is 47.96.
What is the FII and DII holding in Biogen Pharmachem Industries Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.00% of Biogen Pharmachem Industries Ltd. shares.
What sector does Biogen Pharmachem Industries Ltd. belong to?
Biogen Pharmachem Industries Ltd. operates in the Financial Services sector.
What is the beta of Biogen Pharmachem Industries Ltd. stock?
The beta of Biogen Pharmachem Industries Ltd. stock is 0.58, indicating its volatility relative to the broader market.
